A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued.
This study is ongoing, but not recruiting participants.
First Posted: September 20, 2006
Last Update Posted: August 30, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 1, 2017|
|Estimated Primary Completion Date:||December 1, 2017 (Final data collection date for primary outcome measure)|